AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$21.03 USD
+0.66 (3.24%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $21.02 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
AnaptysBio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ANAB 21.03 +0.66(3.24%)
Will ANAB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ANAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANAB
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
ANAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last?
AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
Other News for ANAB
AnaptysBio (ANAB) Target Price Raised by Wedbush | ANAB Stock News
AnaptysBio price target raised by $5 at Wedbush, here's why
Analyst Expectations For AnaptysBio's Future
Notable Two Hundred Day Moving Average Cross - ANAB
AnaptysBio GAAP EPS of -$1.34 beats by $0.21, revenue of $22.26M beats by $10.58M